Autoantibodies to factor VIII with catalytic activity
- 6 November 2002
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 2 (1) , 30-35
- https://doi.org/10.1016/s1568-9972(02)00126-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Prevalence of Proteolytic Antibodies against Factor VIII in Hemophilia ANew England Journal of Medicine, 2002
- Monoclonal Antibody Light Chain with Prothrombinase ActivityBiochemistry, 2000
- Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII InhibitionPublished by Elsevier ,1996
- DNA‐specific antiidiotypic antibodies in the sera of patients with autoimmune diseasesFEBS Letters, 1992
- DNA Hydrolyzing AutoantibodiesScience, 1992
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.Journal of Clinical Investigation, 1989
- Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain.Journal of Clinical Investigation, 1988
- The Immunologic Character of Acquired Inhibitors of Antihemophilic Globulin (Factor VIII) and the Kinetics of Their Interaction with Factor VIII*Journal of Clinical Investigation, 1967
- Nature of Forces between Large Molecules of Biological Interest*Nature, 1948